Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis

Amy S. Paller, Lawrence F. Eichenfield, Alan D. Irvine, Carsten Flohr, Andreas Wollenberg, Sébastien Barbarot, Christine Bangert, Jonathan M. Spergel, Andrew Selfridge, Pinaki Biswas, Haiyun Fan, Justine Alderfer, Melissa Watkins, Herwig Koppensteiner

Open source

DOI
10.1111/all.16512
Published
2025-03-03
Container
Allergy
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/all.16512,
  title = {Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis},
  author = {Amy S. Paller and Lawrence F. Eichenfield and Alan D. Irvine and Carsten Flohr and Andreas Wollenberg and Sébastien Barbarot and Christine Bangert and Jonathan M. Spergel and Andrew Selfridge and Pinaki Biswas and Haiyun Fan and Justine Alderfer and Melissa Watkins and Herwig Koppensteiner},
  year = {2025},
  journal = {Allergy},
  doi = {10.1111/all.16512},
  url = {https://doi.org/10.1111/all.16512}
}

RIS

TY  - JOUR
TI  - Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis
AU  - Amy S. Paller
AU  - Lawrence F. Eichenfield
AU  - Alan D. Irvine
AU  - Carsten Flohr
AU  - Andreas Wollenberg
AU  - Sébastien Barbarot
AU  - Christine Bangert
AU  - Jonathan M. Spergel
AU  - Andrew Selfridge
AU  - Pinaki Biswas
AU  - Haiyun Fan
AU  - Justine Alderfer
AU  - Melissa Watkins
AU  - Herwig Koppensteiner
PY  - 2025
JO  - Allergy
DO  - 10.1111/all.16512
UR  - https://doi.org/10.1111/all.16512
ER  - 

APA

Paller, A. S., Eichenfield, L. F., Irvine, A. D., Flohr, C., Wollenberg, A., Barbarot, S., Bangert, C., Spergel, J. M., Selfridge, A., Biswas, P., Fan, H., Alderfer, J., Watkins, M., & Koppensteiner, H. (2025). Integrated Efficacy and Safety Analysis of Abrocitinib in Adolescents With Moderate‐to‐Severe Atopic Dermatitis. Allergy. https://doi.org/10.1111/all.16512

Source records